Rosa Ana S. D.
- Country
- Spain
- Department
- Neurology
Research Overview
- A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy (X-TOLE4)
- Evaluation of the Safety, Tolerability, and Efficacy of Azetukalner as Adjunctive Therapy in Adults with Focal-Onset Epilepsy: A Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of the Efficacy and Safety of Extended-Release Levetiracetam as Adjunctive Therapy in Refractory Partial Onset Epilepsy: A Randomized, Double-Blind Study
Data & Insights
Has run more than one trial at 57 of 123 partner sites.
Specializations
Epilepsy Management
This investigator specializes in treating various forms of epilepsy, with particular emphasis on drug-resistant seizure disorders. Their research encompasses both established and innovative therapeutic approaches for managing different types of seizures.
- Focal Onset Seizures (FOS)
- Primary Generalized Tonic-Clonic Seizures (PGTCS)
- Refractory Partial Onset Epilepsy
The investigator's work includes evaluation of extended-release formulations and novel therapeutic compounds for enhanced seizure control.
Therapeutic Innovation
Their research focuses on advancing antiepileptic medication development, particularly investigating new therapeutic compounds and comparing different drug delivery mechanisms.
- Extended-Release Formulations
- Novel Anticonvulsant Compounds
- Drug-Resistant Epilepsy Solutions
The investigator's work encompasses both immediate-release and extended-release formulations for optimal therapeutic outcomes.
Clinical Assessment
The investigator conducts comprehensive evaluations of therapeutic interventions in epilepsy, focusing on both efficacy and safety parameters.
- Long-term Safety Monitoring
- Seizure Frequency Assessment
- Treatment Tolerability Studies
Their research includes systematic assessment of treatment responses in patients with various forms of epilepsy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.